Multicenter Clinical Trials Analyzing Efficacy and Safety of Topical Cortex Phellodendri Compound Fluid in Treatment of Diabetic Foot Ulcers

Yali Liu; Youshan Li; Yuqing Du; Tianyi Huang; Chunyan Zhu

doi:10.12659/MSM.923424

20 August 2020: Clinical Research

Multicenter Clinical Trials Analyzing Efficacy and Safety of Topical Cortex Phellodendri Compound Fluid in Treatment of Diabetic Foot Ulcers

Yali Liu ^AE , Youshan Li ^BDF* , Yuqing Du ^BCD , Tianyi Huang ^BCD , Chunyan Zhu ^BEF

DOI: 10.12659/MSM.923424

Med Sci Monit 2020; 26:e923424

Authors information Article notes Copyright and License information

View HTML version

Figure 3 The representative cases before, during, and after CPCF and KFS treatments. (A) DFU before treatment. (B) DFU treated by KFS for 14 days. (C) DFU treated by KFS for 28 days. (A1) DFU before treatment. (B1) DFU treated by CPCF for 14 days. (C1) DFU treated by CPCF for 28 days.

Back to the Article

Multicenter Clinical Trials Analyzing Efficacy and Safety of Topical Cortex Phellodendri Compound Fluid in Treatment of Diabetic Foot Ulcers

Your Privacy